NCI vs GIII

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 30, 2026

NCI

56.8
AI Score
VS
GIII Wins

GIII

69.6
AI Score

Investment Advisor Scores

NCI

57score
Recommendation
HOLD

GIII

70score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NCI GIII Winner
Forward P/E 0 9.3633 Tie
PEG Ratio 1.13 1.2893 NCI
Revenue Growth -50.8% -8.2% GIII
Earnings Growth 34.0% 782.4% GIII
Tradestie Score 56.8/100 69.6/100 GIII
Profit Margin 0.2% 4.3% GIII
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

NCI 1M: +4.2% · 3M: +24.5% GIII 1M: -8.8% · 3M: +3.5%

Current Technical Phase

NCI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.6% over 20 days), RSI 52

RSI (14): 52.2 · Price: $12.57

GIII

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 42.2 · Price: $33.46

Fundamentals Snapshot

Metric NCI GIII
Market Cap
Forward P/E 0.0 11.4
Trailing P/E 154.5 11.7
Revenue (TTM)
Revenue Growth -0.5% -0.1%
Gross Margin 0.4% 0.4%
Operating Margin 0.0% 0.2%
EPS 0.08 2.86
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, GIII is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.